Escalon Medical Corp Stock Revenue
| ESMCDelisted Stock | USD 0.06 0.00 0.00% |
Escalon Medical Corp fundamentals help investors to digest information that contributes to Escalon Medical's financial success or failures. It also enables traders to predict the movement of Escalon OTC Stock. The fundamental analysis module provides a way to measure Escalon Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Escalon Medical otc stock.
Escalon |
Escalon Medical Corp OTC Stock Revenue Analysis
Escalon Medical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Escalon Medical Revenue | 10.7 M |
Most of Escalon Medical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Escalon Medical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Escalon Medical Corp reported 10.7 M of revenue. This is 99.86% lower than that of the Health Care Equipment & Supplies sector and 99.58% lower than that of the Health Care industry. The revenue for all United States stocks is 99.89% higher than that of the company.
Escalon Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Escalon Medical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Escalon Medical could also be used in its relative valuation, which is a method of valuing Escalon Medical by comparing valuation metrics of similar companies.Escalon Medical is currently under evaluation in revenue category among its peers.
Escalon Fundamentals
| Return On Equity | -0.42 | ||||
| Return On Asset | -0.0724 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 2.07 M | ||||
| Shares Outstanding | 7.42 M | ||||
| Shares Owned By Insiders | 1.90 % | ||||
| Number Of Shares Shorted | 2.01 K | ||||
| Price To Earning | 4.50 X | ||||
| Price To Book | 1.12 X | ||||
| Price To Sales | 0.05 X | ||||
| Revenue | 10.7 M | ||||
| Gross Profit | 4.61 M | ||||
| EBITDA | 84.92 K | ||||
| Net Income | 18.08 K | ||||
| Cash And Equivalents | 593.87 K | ||||
| Cash Per Share | 0.08 X | ||||
| Total Debt | 153.43 K | ||||
| Debt To Equity | 0.81 % | ||||
| Current Ratio | 1.39 X | ||||
| Book Value Per Share | 0.07 X | ||||
| Cash Flow From Operations | (1.05 M) | ||||
| Short Ratio | 0.31 X | ||||
| Earnings Per Share | 0.02 X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 41 | ||||
| Beta | -0.39 | ||||
| Market Capitalization | 404.06 K | ||||
| Total Asset | 5.17 M | ||||
| Retained Earnings | (66.22 M) | ||||
| Working Capital | 1.36 M | ||||
| Current Asset | 4.13 M | ||||
| Current Liabilities | 2.78 M | ||||
| Z Score | -13.6 | ||||
| Net Asset | 5.17 M |
About Escalon Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Escalon Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Escalon Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Escalon Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Escalon OTC Stock
If you are still planning to invest in Escalon Medical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Escalon Medical's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |